Ongoing Molecular Nuclear Medicine studies addresses a number of significant unmet diagnostic and medical needs. Curasight supported studies are breast cancer staging and prostate cancer risk stratifications. Others studies shown are academic.

Pipeline diagnostics and therapy Jan 2019